Delivery Order SPE2DB25D3020-SPE2DB25FWGHC

Award Date 3/7/25
Potential Completion Date 3/28/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Amerisourcebergen) for the provision of pharmaceutical products and medical supplies. The contract, valued at up to $12,877.79, is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. This single-award IDC serves as the primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,713.78, is for the supply of XALKORI 250 MG CAPSULE 60S, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $12,877.79 firm fixed price delivery order is for the supply of 4565736120 XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical for delivering a comprehensive range of medical...
This federal contract award, valued at $12,865.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a performance period through December 6, 2024. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,356.89 firm fixed-price contract is for the supply of XALKORI 250 MG CAPSULE 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of March 18, 2025 and was awarded on February 25, 2025. This delivery order is issued under Amerisourcebergen's existing $999,999,999...
This federal contract award is to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, for the supply of the medication XALKORI 250 MG CAPSULE 60S. The award, valued at $12,877.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,451.13 firm fixed price delivery order is for the supply of XELJANZ 10 MG tablet pharmaceuticals. The contract has an ultimate completion date of February 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award, valued at $3,361.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $7,797.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, valued at $4,435.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which supports the provision of a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The award...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWGHC
    Delivery Order

This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,356.89, is for the delivery of XALKORI 250 MG CAPSULE 60S, a medication used in the treatment of certain types of cancer. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience and capabilities in the distribution of a wide array of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other supplies, make the company a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 6/6/25, 9:47 AM